Content about Antitussives

September 1, 2011
California bans sale of dextromethorphan to minors

California on Wednesday banned the sale of dextromethorphan to minors, becoming the first state to pass such legislation.

SACRAMENTO, Calif. — California on Wednesday banned the sale of dextromethorphan to minors, becoming the first state to pass such legislation.

February 23, 2011
Honey Naturals employs social media on competitive product exchange

Honey Naturals last week started offering parents a free bottle of Zarbee’s children’s cough syrup in exchange for a Facebook photo of them discarding a competitive brand of cough syrup.

SANDY, Utah — Honey Naturals last week started offering parents a free bottle of Zarbee’s children’s cough syrup in exchange for a Facebook photo of them discarding a competitive brand of cough syrup.

February 10, 2011
Court: Watson's generic OTC decongestant does not infringe on branded versions

Over-the-counter generic versions of a line of products used to treat congestion do not infringe on the patents covering the branded versions, a federal court ruled Wednesday.

MORRISTOWN, N.J. — Over-the-counter generic versions of a line of products used to treat congestion do not infringe on the patents covering the branded versions, a federal court ruled Wednesday.

December 15, 2010
FDA: Tessalon should be packaged in childproof containers

A prescription cough suppressant should be kept in childproof containers because of its candy-like appearance, the Food and Drug Administration warned Tuesday.

SILVER SPRING, Md. — A prescription cough suppressant should be kept in childproof containers because of its candy-like appearance, the Food and Drug Administration warned Tuesday.

Tessalon (benzonatate) is made by Forest Labs and comes in the form of a round, liquid-filled gelatin capsule. The drug is used to relieve cough in patients older than 10 years of age.

November 21, 2010
FDA asks Xanodyne to pull painkillers from market

A drug maker will pull a common prescription painkiller from the market following the release...

SILVER SPRING, Md. A drug maker will pull a common prescription painkiller from the market following the release of clinical data that it could cause heart problems.

 

October 10, 2010
Industry anxiously awaiting FDA decision on DXM’s fate

While the fact that two Food and Drug Administration advisory committees collectively voted 15 opposed...

October 6, 2010
CADCA, CHPA kick off annual National Medicine Abuse Awareness Month

The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association on Wednesday joined...

WASHINGTON The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association on Wednesday joined forces to kick off their annual National Medicine Abuse Awareness Month to raise awareness of the dangers of youth prescription and over-the-counter medicine abuse.

This initiative, annually held in October, features a coordinated and concentrated effort to educate parents and youth of the potential dangers associated with prescription and OTC medicine abuse.

September 16, 2010
FDA should consult advisory committees on DXM issue

While the advisory committee vote of 15 opposed and nine in favor of scheduling the...

WHAT IT MEANS AND WHY IT’S IMPORTANT While the advisory committee vote of 15 opposed and nine in favor of scheduling the all-too-common cough-relieving ingredient dextromethorphan as a controlled substance might seem like a healthy indicator as to which direction the Food and Drug Administration will act on this issue, make no mistake: it is by no means a certainty. This still may be an issue for cough-cold season 2011-2012.

September 14, 2010
FDA advisory committees forgo restricting cough-cold sales, CHPA responds

A pair of Food and Drug Administration advisory committees on Tuesday evening recommended that the...

WASHINGTON A pair of Food and Drug Administration advisory committees on Tuesday evening recommended that the FDA not place greater sales restrictions on the sale of dextromethorphan by placing the ingredient on the controlled substances schedule. The panel of FDA advisers voted to not schedule DXM by a vote of 15-9.

 

September 13, 2010
NACDS to FDA advisory committee: Curb DXM abuse without impeding appropriate use

As the Food and Drug Administration's Drug Safety and Risk Management Committee debated Tuesday on...

September 9, 2010
CMPI survey: Alcohol, marijuana biggest substance problems among teens

The Center for Medicine in the Public Interest on Thursday released the results of a...

August 31, 2010
FDA to discuss concerns over medicines with DXM

The Food and Drug Administration last week issued an information packet in preparation for a...

SILVER SPRING, Md. The Food and Drug Administration last week issued an information packet in preparation for a Sept. 14 advisory committee meeting that will address the potential abuse of dextromethorphan products and whether restrictions should be placed on the sale of those over-the-counter cough medicines.

 

Members of both the FDA Drug Safety and Risk Management Advisory Committee and the FDA Nonprescription Drugs Advisory Committee will be in attendance at the public meeting.

 

 

June 6, 2010
FDA re-evaluates DXM abuse potential; pharmacy retailers, groups respond

The Food and Drug Administration will be re-evaluating the abuse potential of the cough-cold ingredient...

May 5, 2010
Perrigo acquires rights to generic Delsym cough syrup

Perrigo on Wednesday announced that it has acquired the exclusive U.S. store brand rights to...

May 3, 2010
FDA advisory committee to discuss curbing DXM abuse

The Food and Drug Administration on Tuesday announced through the Federal Register that a Sept....

March 2, 2010
New survey finds teens lack negative perceptions about many drugs

While there was no significant increase in the abuse of over-the-counter cough medicines containing dextromethorphan,...

December 20, 2009
Survey: Adults have trouble picking appropriate treatments for cough symptoms

Consumers can be expected to self-identify a cough, and even locate a cough remedy in...

NEW YORK Consumers can be expected to self-identify a cough, and even locate a cough remedy in the nonprescription aisles. But consumers cannot be expected to distinguish between dextromethorphan and guaifenesin necessarily. Both are indicated for cough relief, but work in entirely different ways. For that you need a readily accessible healthcare professional, such as the pharmacist or nurse practitioner.

 

November 8, 2009
Report: PSE legislation proposal hits Jefferson County, Mo.

The ultimate impact in allowing local municipalities to regulate what’s prescription and what isn’t, will...

NEW YORK The ultimate impact in allowing local municipalities to regulate what’s prescription and what isn’t, will more than quadruple the price of nonprescription medicines, and not just decongestants. And that’s outrageous.

 

September 27, 2009
CHPA, CADCA commend OTC cough medicine abuse legislation

The greater awareness raised around the potential of abuse of drugs commonly stored in the...

NEW YORK The greater awareness raised around the potential of abuse of drugs commonly stored in the consumers’ medicine cabinets among teens, the greater chance of reducing that drug abuse.

 

According to surveys conducted on behalf of the Consumer Healthcare Products Association and others in the past, when a parent talks to their children about drug abuse, it reduces the chances that that child abuses drugs by some 50%.